To the full analysis
Universal Health Services stock: growth
UHSUniversal Health Services reported $17.36B in revenue for fiscal 2025, up 9.7% on the prior year, up 8.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.8%
per year from 2006 to 2025, per share 10.9%
Earnings (Annual rate)
9.6%
per year from 2006 to 2025, per share 12.8%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.5% | 6.7% | 7.8% |
| Revenue per share | 15.0% | 11.6% | 10.9% |
| Earnings | 9.5% | 8.1% | 9.6% |
| Earnings per share | 16.2% | 13.0% | 12.8% |
| Free cash flow | −12.2% | 22.9% | no data |
| Free cash flow per share | −6.9% | 28.4% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.19B | $259.46M | −$171.9M |
| 2007 | $4.75B | $170.39M | $8.68M |
| 2008 | $5.02B | $199.38M | $108.56M |
| 2009 | $5.2B | $260.37M | $153.56M |
| 2010 | $5.57B | $230.18M | $262.07M |
| 2011 | $7.5B | $398.17M | $394.32M |
| 2012 | $6.96B | $443.45M | −$75.77M |
| 2013 | $7.28B | $510.73M | $513.11M |
| 2014 | $8.07B | $545.34M | $213.34M |
| 2015 | $9.04B | $680.53M | $107.92M |
| 2016 | $9.77B | $702.41M | $133.26M |
| 2017 | $10.41B | $752.3M | $573.15M |
| 2018 | $10.77B | $779.71M | $529.22M |
| 2019 | $11.38B | $814.85M | $774.95M |
| 2020 | $11.56B | $943.95M | $1.63B |
| 2021 | $12.64B | $991.59M | $28.04M |
| 2022 | $13.4B | $675.61M | $262.02M |
| 2023 | $14.28B | $717.8M | $524.74M |
| 2024 | $15.83B | $1.14B | $1.12B |
| 2025 | $17.36B | $1.49B | $849.25M |
Revenue by segment
How Universal Health Services, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Acute Care Hospital Services57%
- Behavioral Health Services43%
Figures as a table
| 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|
| Acute Care Hospital Services | $7.11B | $7.65B | $8.08B | $8.92B | $9.93B | 57.2% |
| Behavioral Health Services | $5.5B | $5.73B | $6.19B | $6.9B | $7.43B | 42.8% |
| Total revenue | $12.64B | $13.4B | $14.28B | $15.83B | $17.36B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.